06222018Headline:

New York, New York

HomeNew YorkNew York

Eric T. Chaffin

FDA Announces New Steps to Crack Down on Sale of E-Cigarettes to Minors

In December 2016, the Centers for Disease Control and Prevention (CDC) reported that electronic cigarettes had become the most commonly used tobacco product among U.S. youths. In 2015, about 5.3 percent of middle school students and 16 percent of high […]

Eric T. Chaffin

Allergan Recalls Nearly 170,000 TAYTULLA Sample Packs

On May 29, 2018, pharmaceutical company Allergan announced the recall of nearly 170,000 packets of Taytulla birth control capsules.  Allergan had distributed the contraceptives to doctors nationwide for use as free samples for patients. A manufacturing error caused the capsules […]

Roopal Luhana

After Reports of Related Deaths, FDA Reviewing Safety of Parkinson’s Drug Nuplazid

Currently, Nuplazid (pimavanserin), marketed by Acadia Pharmaceuticals Inc., is the only medication approved by the FDA to treat the hallucinations and mental delusions associated with Parkinson’s disease psychosis. The FDA is now taking another look at the drug, however, after […]

Roopal Luhana

Merck Files Motion to Consolidate Zostavax Lawsuits in Florida

Merck & Co., Inc., makers of the shingles vaccine Zostavax, recently filed a motion to transfer all Zostavax lawsuits to one court for coordinated pre-trial proceedings. There are currently nearly 60 lawsuits pending in Federal District courts around the country, […]

Roopal Luhana

Kentucky Woman Blames Onglyza Manufacturers for Heart Failure

On March 26, 2018, a Kentucky woman filed a new Onglyza lawsuit against manufacturers Bristol-Myers Squibb and AstraZeneca. She claims that after taking the type-2 diabetes drug, she suffered from serious injuries, and seeks compensation for her medical expenses and […]

Eric T. Chaffin

FDA Working with Manufacturers on Nationwide Withdrawal of MS Drug Zinbryta

On March 2, 2018, pharmaceutical companies Biogen and AbbVie announced the worldwide withdrawal of the drug Zinbryta (daclizumab), which is used to help treat multiple sclerosis (MS). In a related press release, the companies stated that the recall was “in […]

Roopal Luhana

Arizona Woman Blames Jardiance for Diabetic Ketoacidosis

On March 1, 2018, an Arizona woman filed a new Jardiance lawsuit against manufacturers Boehringer Ingelheim, claiming the type 2 diabetes medication caused her to suffer from serious injuries. She filed the case in the U.S. District Court for the […]

Roopal Luhana

New Onglyza Lawsuit Claims Drug Led to Heart Failure

In late February 2018, an Ohio woman, as representative of a male family member, filed a new Onglyza lawsuit in the U.S. District Court for the Southern District of Ohio. This case now joins a number of other similar cases […]

Roopal Luhana

North Carolina Woman Claims Kombiglyze XR Caused Congestive Heart Failure

On January 23, 2018, a North Carolina woman filed a new Kombiglyze XR (saxagliptin and metformin) lawsuit against manufacturers Bristol-Myers Squibb and AstraZeneca. She claims that after taking the diabetes medication, she suffered serious injuries that required hospitalization. She filed […]

Roopal Luhana

Illinois Man Blames Onglyza for his Heart Failure

On January 9, 2018, an Illinois man filed a new Onglyza lawsuit in the U.S. District Court for the Central District of Illinois.  He claims that after taking the diabetes medication, he suffered serious injuries.  He seeks in excess of […]